Fulton appoints new management team
Restructures Bristol-based business
Following the retirement of the UK firm’s sales and marketing and technical directors, Fulton Inc has restructured the business and appointed Paul Richards as managing director and Carl Knight as UK and European sales and marketing manager.
Richards previously worked for Solatron, while Knight joins Fulton from Spirax Sarco.
Richards said: ‘The changes haven’t just stopped with management appointments. We have also restructured and changed the trading name from Fulton Boiler Works (GB) to Fulton, as we feel it better reflects the business and markets we now operate in.’
Once just a steam boiler manufacturer, Fulton now specialises in the design and manufacture of energy efficient products and ready-to-ship skid mounted and fully packaged boiler plant rooms, he added.
‘We put great emphasis on providing sales and application advice and a full commissioning and after sales service to a growing customer base in hospital and healthcare facilities, food and beverage processing, laundries and other applications.’
Fulton recently introduced of a VMP vertical tubeless boiler, ModSync boiler sequencing system and TDS energy recovery system.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing
Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Manufacturing
Symbiosis completes full ICH climatic zone coverage with new stability chamber addition
Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets